Symbol
PTC Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$43.24
Current price of the stock
$1M
Trading volume of the stock
$3.3B
Market capitalization of the company
Mid Cap
Category of market capitalization
14.13%
Long-term growth mean estimate
3.81
Mean analyst rating
47.39%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-2.26
Total debt to total equity ratio
2.10
Current ratio
94.49%
Gross profit margin
-27.70%
Operating profit margin
-27.70%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-49.80%
Pretax profit margin
-54.20%
Net profit margin
10.12%
Measures profitability relative to shareholders' equity
7.27%
ROE excluding intangible assets
-5.79%
Measures profitability relative to total assets
-9.96%
Measures profitability relative to invested capital
0.11
Asset turnover ratio
0.30
Inventory turnover ratio
0.98
Receivables turnover ratio
91.46
Average number of days it takes to collect receivables
-7.27
Measures valuation relative to earnings
-25.14
P/E based on future earnings estimates
3.69
Measures valuation relative to sales
-3.16
Measures valuation relative to book value
-19.56
Measures valuation relative to operating cash flow
-21.09
Measures valuation relative to free cash flow
-147
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC